a Delaware corporation) 6,500,000 Shares of Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • January 30th, 2023 • Paragon 28, Inc. • Surgical & medical instruments & apparatus • New York
Reference is made to the Underwriting Agreement, dated as of January 25, 2023 (the “Underwriting Agreement”), by and among Paragon 28, Inc., a Delaware corporation (the “Company”), and BofA Securities, Inc. and Piper Sandler & Co., as representatives of the several underwriters named therein (collectively, the “Underwriters”), and the prospectus and preliminary prospectus supplement and the documents incorporated by reference therein, dated as of January 25, 2023 (the “Prospectus”), with respect to the offering of an aggregate of 6,500,000 shares of common stock, par value $0.01 per share (the “Common Stock”), of the Company. Capitalized terms used but not defined in this certificate have the meaning ascribed to them in the Underwriting Agreement.
